February 2007

 |
| Imaging |
 |
|
 |
 |
Cardiac resynchronization in a patient with Class IV heart failure and narrow QRS-the role of mechanical dyssynchrony |
| |
by Joseph Dell’Orfano, MD |
| |
From Arrhythmia Consultants of Connecticut, Hartford. |
 |
 |
 |
| Diabetes |
 |
|
 |
 |
Is circulating heat shock protein 60 a marker for susceptibility to cardiovascular disease in patients with diabetes? |
| |
by Brian Henderson, PhD1 • Jeffrey W. Stevens MD, PhD2 • Jacqueline A. Cooper, BSc2 • Andrew Steptoe, DSc3 • Anthony R.M. Coates, MD4 • Steve E. Humphries, PhD, FRCPath, MRCP2 • Alireza Shamaei-Tousi, PhD1 |
| |
From the 1Division of Microbial Diseases, UCL Eastman Dental Institute; 2Centre for Cardiovascular Genetics, British Heart Foundation Laboratories; 3Department of Epidemiology and Public Health, all at University College London, United Kingdom; and 4Department of Cellular and Molecular Medicine, St George's University of London, United Kingdom. |
 |
 |
| |
Commentary |
 |
Prevalent atherosclerosis-Choose your biomarker |
| |
by Tasneem Z. Naqvi, MD |
 |
 |
 |
| Arrhythmias |
 |
|
 |
 |
Nonischemic cardiomyopathy and implantable cardioverter-defibrillators |
| |
by Elizabeth J. Masterson, MD Alan H. Kadish, MD |
| |
From the Clinical Trials Unit, Bluhm Cardiovascular Institute, Northwestern Memorial Hospital, the Division of Cardiology, Feinberg School of Medicine, Chicago, Illinois. |
 |
 |
| |
Case Report |
 |
Implantable cardioverter-defibrillator therapy for a woman with nonischemic cardiomyopathy |
 |
 |
| |
Commentary |
 |
Nonischemic cardiomyopathy and implantable defibrillators: timing is everything |
| |
by Joseph Dell'Orfano, MD |
 |
 |
 |
| Hypertension |
 |
|
 |
 |
C-reactive protein and hypertension |
| |
by Susan G. Lakoski, MD, MS1 • David M. Siscovick, MD, MPH2 • David M. Herrington, MD, MHS1 |
| |
From the 1Department of Internal Medicine/Cardiology,Wake Forest University School of Medicine, Winston-Salem, North Carolina; and 2Department of Medicine and Epidemiology, University of Washington, Seattle. |
 |
 |
| |
Commentary |
 |
Can C-reactive protein levels predict risk of hypertension in a younger population? |
| |
by Samuel. J. Mann, MD |
 |
|
 |
 |
 |
 |
 |

 |
| Departments |
 |

|
|
|
 |
|